Improved compression properties of propyphenazone spherical crystals

International Journal of Pharmaceutics

Volumn 197, Issue 1-2, 2000, Pages 95-106

  Di Martino, Piera ^a   Di Cristofaro, Roberta ^a   Barthélémy, Christine ^b   Joiris, Etienne ^b   Palmieri Filippo, Giovanni ^a   Sante, Martelli ^a  

^a Laboratorio di Tecnica Farmaceutica   (Italy)

^b UNIV LILLE   (France)

Author keywords

Brittle fracture; Compression behavior; Propyphenazone; Spherical crystallization

Indexed keywords

ALCOHOL; PROPYPHENAZONE; SOLVENT;

ARTICLE; CRYSTALLIZATION; DRUG FORMULATION; DRUG MANUFACTURE; PARTICLE SIZE; PHYSICAL PARAMETERS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TABLET; TABLET FORMULATION; TENSILE STRENGTH;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRINE; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG COMPOUNDING; ELASTICITY; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POWDERS; PRESSURE; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 0034000953     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00455-X     Document Type: Article

References (24)

1. Akbuga J. Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization. Int. J. Pharm. 53:1989;99-105.
2. Armstrong N.A., Haines-Nutt R.F. Elastic recovery and surface area changes in compacted powder systems. Powder Technol. 9:1974;287-290.
3. Carr R.L. Evaluating flow properties of solids. Chem. Eng. 72:1965a;163-168.
4. Carr R.L. Classifying flow properties of solids. Chem. Eng. 72:1965b;69-72.
5. Di Martino P., Barthelemy C., Piva F., Joiris E., Palmieri G.F., Martelli S. Improved dissolution behavior of fenbufen by spherical crystallization. Drug Dev. Ind. Pharm. 25:1999;1073-1081.
6. Doelker E. Assessment of powder compaction. Chulia D., Deleuil M., Pourcelot Y. Powder Technology and Pharmaceutical Process. 1994;403-471 Elsevier, Amsterdam.
7. Eriksson M., Alderborn G. The effect of the original particle size and tablet porosity on the increase in tensile strength during storage of sodium chloride tablets in a dry atmosphere. Int. J. Pharm. 113:1995;199-207.
8. Fell J.T., Newton J.M. Determination of tablet strength by the diametral-compression test. J. Pharm. Sci. 5:1970;688-691.
9. Guillaume F., Guyot-Hermann A.M., Guyot J.C. Spherical crystallization of meprobamate. Il Farmaco. 48:1993;473-485.
10. Heckel R.W. Density-pressure relationships in powder compaction. Trans. Metall. Soc. AIME. 221:1961;661-675.
11. Joiris E., Di Martino P., Berneron C., Guyot-Hermann A-M., Guyot J.C. Compression behavior of orthorhombic paracetamol. Pharm. Res. 15:1998;1122-1130.
12. Juslin M.J., Paronen T.P. On the accuracy of displacement measurements by instrumented single-punch machine. J. Pharm. Pharmacol. 32:1980;796-798.
13. Kawashima Y. Part 1. New processes. Application of spherical crystallization to particulate design of pharmaceuticals for direct tabletting and coating and new drug delivery system. Chulia D., Deleuil M., Pourcelot Y. Powder Technology and Pharmaceutical Process. 1994a;493-512 Elsevier, Amsterdam.
14. Kawashima Y., Cui F., Takeuchi H., Niwa T., Hino T., Kiuchi K. Improvements in flowability and compressibility of pharmaceutical crystals for direct tabletting by spherical crystallization with a two-solvent system. Powder Technol. 78:1994b;151-157.
15. Kawashima Y., Handa T., Takeuchi H., Okumura M., Katou H., Nagata O. Crystal modification of phenytoin with polyethylene glycol for improving mechanical strength, dissolution rate and bioavailability by a spherical crystallization technique. Chem. Pharm. Bull. 34:1986;3376-3383.
16. Kawashima Y., Takenaka H. Development of agglomeration process by using a flocculation phenomenon of particle in liquid and the applications to pharmaceutical system. Hyomen. 22:1984;719-728.
17. Lefebvre, C., Guillaume, F., Bouché, R., Bouaziz, R., Guyot, J.C., 1989. Etude de différentes formes polymorphes du meprobamate. In: Fifth International Conference On Pharmaceutical Technology, Paris, vol. I, pp. 211-221.
18. Martindale, 1996. The Extra Pharmacopoeia, 31st ed. Royal Pharmaceutical Society, London, p. 93.
19. Paronen P., Ilkka J. Porosity-pressure functions. Alderborn G., Nyström Pharmaceutical Powder Compaction Technology. 1996;55-75 Marcel Dekker, New York.
20. Puechagut H.G., Bianchotti J., Chiale C.A. Preparation of norfloxacin spherical agglomerates using the ammonia diffusion system. J. Pharm. Sci. 87:1998;519-523.
21. Ribardière A., Tchoreloff P., Couarraze G., Puisieux F. Modification of ketoprofen bead structure produced by the spherical crystallization technique with a two-solvent system. Int. J. Pharm. 144:1996;195-207.
22. Sano A., Kuriki T., Kawashima Y., Takeuchi H., Hino T., Niwa T. Particle design of tolbutamide by spherical crystallization technique. V. Improvement of dissolution and bioavailability of direct compressed tablets prepared using tolbutamide agglomerated crystals. Chem. Pharm. Bull. 40:1992;3030-3035.
23. Shangraw R.F. Compressed tablets by direct compression. Lieberman H.A., Lachman L., Schwartz J.B. Pharmaceutical Dosage Forms: Tablets. 1:1989;195-246 Marcel Dekker, New York.
24. Sheffé, H., 1958. Experiments with mitxures. J. R. Stat. Soc.Ser. B., 20, 344-360.